DK630088A - Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel - Google Patents

Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel

Info

Publication number
DK630088A
DK630088A DK630088A DK630088A DK630088A DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A
Authority
DK
Denmark
Prior art keywords
azelastinembonate
procedures
preparing
compound
active agent
Prior art date
Application number
DK630088A
Other languages
English (en)
Other versions
DK170339B1 (da
DK630088D0 (da
Inventor
Gerhard Scheffler
Dieter Sauerbier
Juergen Engel
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK630088D0 publication Critical patent/DK630088D0/da
Publication of DK630088A publication Critical patent/DK630088A/da
Application granted granted Critical
Publication of DK170339B1 publication Critical patent/DK170339B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK630088A 1987-11-13 1988-11-11 Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler DK170339B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
SG153894 1994-10-21

Publications (3)

Publication Number Publication Date
DK630088D0 DK630088D0 (da) 1988-11-11
DK630088A true DK630088A (da) 1989-05-14
DK170339B1 DK170339B1 (da) 1995-08-07

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK630088A DK170339B1 (da) 1987-11-13 1988-11-11 Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler

Country Status (9)

Country Link
EP (1) EP0316639B1 (da)
JP (1) JP2730581B2 (da)
AT (1) ATE106883T1 (da)
CA (1) CA1317595C (da)
DE (1) DE3850044D1 (da)
DK (1) DK170339B1 (da)
ES (1) ES2053679T3 (da)
HK (1) HK135494A (da)
SG (1) SG153894G (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0396069T3 (da) * 1989-05-05 1994-07-25 Asta Medica Ag Salte af azelastin med forbedret opløselighed
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
NZ555501A (en) 2004-11-24 2010-01-29 Medpointe Healthcare Inc Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (da) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
DK170339B1 (da) 1995-08-07
DK630088D0 (da) 1988-11-11
SG153894G (en) 1995-03-17
EP0316639B1 (de) 1994-06-08
JP2730581B2 (ja) 1998-03-25
DE3850044D1 (de) 1994-07-14
HK135494A (en) 1994-12-09
ES2053679T3 (es) 1994-08-01
ATE106883T1 (de) 1994-06-15
EP0316639A2 (de) 1989-05-24
CA1317595C (en) 1993-05-11
JPH01153686A (ja) 1989-06-15
EP0316639A3 (en) 1990-07-18

Similar Documents

Publication Publication Date Title
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
ATE216590T1 (de) Arzneimittelformulierungen für il-12
PT83872A (de) Arzneimittel
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
DK605786D0 (da) Stabiliserede human-vaevsplasminogenaktivator-praeparater
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
DK0508220T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf
DK127588A (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK630088A (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
NO883047L (no) Substituerte benzimidazoler, fremgangsmaate til deres fremstilling, farmasoeytiske tilberedninger inneholdende dem ogderes anvendelse.
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
FI884545A (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
DK88087D0 (da) Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem
DK524489A (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
DK4287D0 (da) Polyfluoralkylthiomethyl-forbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanneforbindelser som overfladeaktive midler
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
IT8219652A0 (it) Derivato della propionilglicina, processi per la sua preparazione e composizioni terapeutiche che lo contengono come principio attivo.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired